Table 1.
Primers used for gene sequencing of erm(41), rrl and rrs.
Table 2.
Drug susceptibility patterns of Mycobacterium abscessus isolates from clinical specimens of patients in Northeast Thailand.
Table 3.
Comparisons of drug susceptibility pattern in massiliense and non-massiliense subspecies of M. abscessus isolated from clinical specimens.
Fig 1.
Drug susceptibility patterns of M. abscessus serially isolated from individual patients (P#1-P#26).
Only susceptible (green letters) or intermediate (purple letters) levels of drug sensitivity are shown, except for “CLA” for which “IR” (inducible resistance) and “R” (acquired resistance) are shown. Organ sites are shown except pulmonary sites. Reinfection or recolonization strains (different strain among serial isolates– 2 patients) are excluded. “NONE” refers to resistance to all 15 antibiotics. The timeline shows number of days between successive samplings. a These cases were defined as colonization. AMK = Amikacin, FOX = Cefoxitin, CLA = Clarithromycin, DOX = Doxycycline, LZD = Linezolid, MFX = Moxifloxacin, Min = Minocycline, TGC = Tigecycline.
Table 4.
Association between gene sequence and MIC levels for clarithromycin and amikacin.
Table 5.
Analysis between erm(41) gene sequence and clarithromycin susceptibility.
Table 6.
Comparison of SNPs of the erm(41) gene and MIC level for clarithromycin.
Table 7.
Association between rrl gene sequence and clarithromycin susceptibility in M. abscessus (n = 64).
Table 8.
Association between SNP of rrl gene and MIC level (μg/ml) for clarithromycin.